The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer ...
The field of movement disorders, particularly tremor syndromes, is undergoing a transformative shift driven by advancements in precision medicine. Tremor, a ...
Onasemnogene abeparvovec-brve is the first gene replacement therapy approved for SMA patients aged 2 years and older, expanding access beyond infants. Phase 3 trials demonstrated significant motor ...
Patients with desmoid tumors face significant clinical and economic burdens, impacting their quality of life and leading to ...
Background/Aims Diabetic retinopathy (DR) is a major ocular complication of diabetes mellitus. While artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback